These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8043318)

  • 1. Toxicity of a novel HMG-CoA reductase inhibitor in the common marmoset (Callithrix jacchus).
    Owen K; Pick CR; Libretto SE; Adams MJ
    Hum Exp Toxicol; 1994 May; 13(5):357-68. PubMed ID: 8043318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats.
    Henck JW; Craft WR; Black A; Colgin J; Anderson JA
    Toxicol Sci; 1998 Jan; 41(1):88-99. PubMed ID: 9520344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-month repeated oral toxicity study of NK-104 in rats.
    Akiba T; Shibuta T; Amano Y; Asanuma A; Okubo M; Nishigaki K; Moriwaki T; Yamada H; Okamura N; Watanabe T; Koga T; Tanaka M; Takimoto M
    J Toxicol Sci; 1998 Nov; 23 Suppl 5():713-20. PubMed ID: 9891909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subacute toxicity of a halogenated pyrrole hydroxymethylglutaryl-coenzyme A reductase inhibitor in Wistar rats.
    Sigler RE; Dominick MA; McGuire EJ
    Toxicol Pathol; 1992; 20(4):595-602. PubMed ID: 1308625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.
    Regazzi MB; Iacona I; Campana C; Gavazzi A; Viganò M; Perani G
    Transplant Proc; 1994 Oct; 26(5):2644-5. PubMed ID: 7940825
    [No Abstract]   [Full Text] [Related]  

  • 7. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
    Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
    Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose combination of alendronate and atorvastatin reduces ligature-induced alveolar bone loss in rats.
    Goes P; Melo IM; Silva LM; Benevides NM; Alencar NM; Ribeiro RA; Lima V
    J Periodontal Res; 2014 Feb; 49(1):45-54. PubMed ID: 23742139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental toxicity of the HMG-CoA reductase inhibitor (PPD10558) in rats and rabbits.
    Faqi AS; Prohaska D; Lopez R; McIntyre G
    Birth Defects Res B Dev Reprod Toxicol; 2012 Feb; 95(1):23-37. PubMed ID: 22006546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma aminotransferase measurements in the marmoset (Callithrix jacchus).
    Cowie JR; Evans GO
    Lab Anim; 1985 Jan; 19(1):48-50. PubMed ID: 3919214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.
    Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J
    Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feeding status-related effects of 17 beta-estradiol on liver 3-hydroxy-3-methylglutaryl CoA reductase.
    Alonso MA; Fernandez de Quincoces A; Lacort M; Gandarias JM; Ochoa B
    Exp Clin Endocrinol; 1993; 101(3):123-30. PubMed ID: 8223979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study.
    Nakahara K; Kuriyama M; Sonoda Y; Yoshidome H; Nakagawa H; Fujiyama J; Higuchi I; Osame M
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):99-106. PubMed ID: 9772205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to the skeletal muscle injury expressed by repeated treatment with compound A that has HMG-CoA reductase inhibitory activity.
    Tanaka K; Kiyosawa N; Honda K; Sharyo S; Ito K; Teranishi M; Manabe S
    J Toxicol Sci; 2007 Feb; 32(1):9-18. PubMed ID: 17327690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on the development of myopathy in young rats.
    Reijneveld JC; Koot RW; Bredman JJ; Joles JA; Bär PR
    Pediatr Res; 1996 Jun; 39(6):1028-35. PubMed ID: 8725265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intragastric infection induced in marmosets (Callithrix jacchus) by a Brazilian hepatitis A virus (HAF-203).
    Vitral CL; Marchevsky RS; Yoshida CF; Coelho JM; Gaspar AM; Schatzmayr HG
    Braz J Med Biol Res; 1995 Mar; 28(3):313-21. PubMed ID: 8520524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy.
    Tzefos M; Olin JL
    J Clin Lipidol; 2011; 5(6):450-9. PubMed ID: 22108148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the toxicity of indomethacin in a 4-week study, by oral route, in the marmoset (Callithrix jacchus).
    Oberto G; Conz A; Giachetti C; Galli CL
    Fundam Appl Toxicol; 1990 Nov; 15(4):800-13. PubMed ID: 2086319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
    Schuler LA; Toaff ME; Strauss JF
    Endocrinology; 1981 Apr; 108(4):1476-86. PubMed ID: 7472277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.